INmune Bio Inc. (INMB)
NASDAQ: INMB
· Real-Time Price · USD
2.53
0.08 (3.27%)
At close: Aug 15, 2025, 3:59 PM
2.47
-2.37%
After-hours: Aug 15, 2025, 07:51 PM EDT
INmune Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 50K | 50K | 14K | 42K | 85K | 131K | 155K | 224K | 279K | 249K | 374K | 440K | 356K | 340K | 181K | 28.92K | 14.92K | 14.92K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 50K | 50K | 14K | 42K | 85K | 131K | 155K | 224K | 279K | 249K | 374K | 440K | 356K | 340K | 181K | 28.92K | 14.92K | 14.92K |
Operating Income | -56.23M | -41.52M | -42.63M | -41.55M | -37.79M | -34.34M | -29.74M | -27M | -25.92M | -25.9M | -25.95M | -29.34M | -30.92M | -31.08M | -29.15M | -23.33M | -19.13M | -14.68M |
Interest Income | n/a | n/a | n/a | n/a | 568K | 1.2M | 1.81M | 3.23M | 3.19M | 2.56M | 1.95M | 525K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -55.51M | -40.8M | -42.08M | -41.27M | -37.74M | -34.5M | -30.01M | -27.43M | -26.59M | -26.93M | -27.3M | -31.14M | -32.87M | -32.69M | -30.34M | -23.87M | -19.13M | -14.59M |
Net Income | -55.51M | -40.8M | -42.08M | -41.27M | -37.74M | -34.5M | -30.12M | -27.74M | -27.18M | -27.97M | -28.65M | -32.29M | -33.74M | -33.11M | -30.34M | -23.87M | -19.13M | -14.59M |
Selling & General & Admin | 8.9M | 9.46M | 9.48M | 9.77M | 10.14M | 9.63M | 9.62M | 9.55M | 9.35M | 9.25M | 9.26M | 9.05M | 9.19M | 9.06M | 8.79M | 8.03M | 7.97M | 7.08M |
Research & Development | 30.86M | 32.11M | 33.17M | 31.82M | 27.74M | 24.83M | 20.27M | 17.68M | 16.85M | 16.89M | 17.07M | 20.73M | 22.09M | 22.36M | 20.54M | 15.33M | 11.18M | 7.62M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8K | -3.43K | -3.43K | -3.82K |
Operating Expenses | 39.77M | 41.57M | 42.65M | 41.59M | 37.87M | 34.47M | 29.9M | 27.23M | 26.2M | 26.14M | 26.32M | 29.78M | 31.27M | 31.42M | 29.33M | 23.36M | 19.14M | 14.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 113K | 304K | 586K | 1.04M | 1.35M | 22.47M | 22.18M | 21.73M | 21.31M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 41K | 41K | 41K | 41K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.77M | 41.57M | 42.65M | 41.59M | 37.87M | 34.47M | 29.9M | 27.23M | 26.2M | 26.14M | 26.32M | 29.78M | 31.27M | 31.42M | 29.33M | 23.36M | 19.14M | 14.7M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 113K | 304K | 586K | 1.04M | 1.35M | 1.16M | 875K | 425K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 23.3M | 22.5M | 22.28M | 20.19M | 19.31M | 18.03M | 17.95M | 18.01M | 17.95M | 17.95M | 17.93M | 17.95M | 17.95M | 17.87M | 17.33M | 17.33M | 14.97M | 14.32M |
Shares Outstanding (Diluted) | 23.3M | 22.5M | 22.28M | 20.19M | 19.31M | 18.03M | 17.95M | 18.01M | 17.95M | 17.95M | 17.93M | 17.95M | 17.95M | 17.87M | 17.33M | 17.33M | 14.97M | 14.32M |
EPS (Basic) | -2.49 | -1.94 | -2.12 | -2.18 | -2.06 | -1.92 | -1.68 | -1.55 | -1.52 | -1.57 | -1.61 | -1.83 | -1.93 | -1.96 | -1.87 | -1.56 | -1.37 | -1.13 |
EPS (Diluted) | -2.49 | -1.94 | -2.12 | -2.18 | -2.06 | -1.92 | -1.68 | -1.55 | -1.52 | -1.57 | -1.61 | -1.83 | -1.93 | -1.96 | -1.87 | -1.56 | -1.37 | -1.13 |
EBITDA | -55.98M | -41.27M | -42.39M | -41.55M | -37.79M | -34.34M | -29.74M | -27M | -25.92M | -25.9M | -25.95M | -29.34M | -30.92M | -31.08M | -29.15M | -23.33M | -19.13M | -14.68M |
EBIT | -55.87M | -41.27M | -42.39M | -41.58M | -37.83M | -34.37M | -29.77M | -27.2M | -26.11M | -26.09M | -26.57M | -30.41M | -32.42M | -32.69M | -30.34M | -23.88M | -19.24M | -14.69M |
Depreciation & Amortization | n/a | 9.87M | 9.87M | 9.87M | 18.39M | 14.94M | 21.36M | 27M | 25.92M | 25.9M | 25.95M | 29.34M | 30.92M | 31.08M | 29.15M | 23.33M | 19.13M | 14.68M |